Synarel (nafarelin acetate) — Point32Health

Initial criteria

• Patient age ≥ 18 years
• Documented diagnosis of endometriosis by OB/GYN
• Patient has moderate to severe pain associated with endometriosis
• Member has had an insufficient response or intolerance to generic alternatives in two of the following classes: nonsteroidal anti-inflammatory drugs (NSAIDs); hormonal contraceptives; oral danazol; oral or depot medroxyprogesterone; oral norethindrone

Approval duration

6 months